Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.22 USD
Change Today -0.05 / -0.80%
Volume 230.7K
CYTK On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

cytokinetics inc (CYTK) Key Developments

Cytokinetics, Incorporated - Analyst/Investor Day

Cytokinetics, Incorporated - Analyst/Investor Day

Cytokinetics, Incorporated Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Cytokinetics, Incorporated reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total revenues of $4,414,000 compared to $7,979,000 a year ago. Net loss was $8,872,000 or $0.23 per basic share and diluted share compared to a net loss of $8,744,000, or $0.27 per basic and diluted share. Operating loss was $8,909,000 against $8,770,000 a year ago.

Cytokinetics, Incorporated to Report Q1, 2015 Results on Apr 30, 2015

Cytokinetics, Incorporated announced that they will report Q1, 2015 results at 4:00 PM, US Eastern Standard Time on Apr 30, 2015

Cytokinetics, Incorporated, Q1 2015 Earnings Call, Apr 30, 2015

Cytokinetics, Incorporated, Q1 2015 Earnings Call, Apr 30, 2015

Cytokinetics, Incorporated - Shareholder/Analyst Call

Annual Meeting of Stockholders

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTK:US $6.22 USD -0.05

CYTK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ArQule Inc $1.81 USD -0.065
CTI BioPharma Corp $1.71 USD -0.03
Curis Inc $3.04 USD -0.06
Exelixis Inc $3.15 USD +0.01
GlaxoSmithKline SAE £11.61 EGP +0.09
View Industry Companies
 

Industry Analysis

CYTK

Industry Average

Valuation CYTK Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.5x
Price/Book 2.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTOKINETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.